Mustafa Atci

16PUBLICATIONS

81CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursCancer genetics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (16)

Sort by Publication Date:

|May 12, 2026

Prognostic factors and survival outcomes in older adults with extensive-stage small cell lung cancer: A multicenter retrospective cohort study.

|Apr 27, 2026

Perioperative FLOT versus Definitive 50.4 Gy Chemoradiotherapy in Siewert II Esophagogastric Junction Adenocarcinoma: A Multicenter Retrospective Cohort Study.

|Aug 27, 2025

Bevacizumab Efficacy and Tolerability in Patients with Metastatic Platinum-Sensitive Ovarian Cancer Beyond Progression.

Mert Erciyestepe, Şermin Dinç Sonuşen, Şaban Seçmeler

|Feb 17, 2025

Perioperative 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in gastric cancer: Pathological regression grade and its relationship to clinical outcome.

Muhammed M Atci, Saban Secmeler, Abdullah Sakin

|Aug 02, 2022

Real-life analysis of treatment approaches and the role of inflammatory markers on survival in patients with advanced biliary tract cancer.

Sabin Goktas Aydin, Burcin Cakan Demirel, Ahmet Bilici

|May 11, 2022

Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?

Özgecan Dülgar, Başak Bala Öven, Muhammed Mustafa Atcı

Pageof 3

Frequent Collaborators

Abdullah Sakin

Seval Ay

Baran Akagunduz

Saban Secmeler

Muhammet Ozer

Sermin Dinc Sonusen

Emir Celik

Caglayan Geredeli

Sener Cihan

Rukiye Arıkan

Frequent Collaborators

Abdullah Sakin

Seval Ay

Baran Akagunduz

Saban Secmeler